TY  - JOUR 
AU  - Rio-Vilariño, Anxo
AU  - Garcia-Bautista, Ana
AU  - Cenigaonandia-Campillo, Aiora
AU  - Mateos-Gomez, Pedro A.
AU  - Garcia-Garcia, Laura
AU  - Schlaepfer, Marina I.
AU  - Garcia-Hernandez, Laura
AU  - Puerto-Nevado, Laura del
AU  - Aguilera, Oscar
AU  - Baños, Natalia
AU  - Minguez, Pablo
AU  - Castellano, Víctor Manuel
AU  - García-Foncillas, Jesús
AU  - Cebrian, Arancha
PY  - 2025
UR  - https://hdl.handle.net/20.500.12766/808
AB  - Anti-epidermal growth factor receptor (EGFR) therapies are the most recommended first-line treatment for RAS/RAF wild-type unresectable metastatic colorectal cancer (CRC) according to the European Society for Medical Oncology guidelines. However,...
LA  - eng
PB  - Elsevier Inc.
TI  - Aurora kinase A drives non-canonical YAP1/TAZ crosstalk to sustain primary resistance to anti-EGFR therapies in colorectal cancer
DO  - 10.1016/j.omton.2025.201032
T2  - Molecular Therapy: Oncology
M2  - 1
KW  - Anti-EGFR
KW  - Aurora kinase A
KW  - Cancer stem cells
KW  - Cetuximab
KW  - Drug resistance
KW  - Metastatic colorectal cancer
KW  - Non-canonical Hippo pathway
KW  - TAZ
KW  - YAP1
VL  - 33
ER  -